Skip to content
Cryptos: 608Market Cap: $3.29T 0.3%24h Vol: $51.94BDominance: BTC 46.2% ETH 8.3%
Open Tradzy

Big move · Turkey stocks

Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN) jumps 9.0% to TRY 12.22

Its fourth straight daily rise.

Published 6 November 2026 · Written from Tradzy's price and volume data

Close
TRY 12.22
On the day
+9.0%
Volume
1.2× average
vs 52-week high
−43.8%

Biotrend Cevre ve Enerji Yatirimlari A.S. closing prices

TRY 10.00TRY 15.00TRY 20.00Jul '26Jul '26Aug '26Sep '26Oct '26Nov '26TRY 12.22

The last 90 closes up to 6 November 2026. The live chart is on the BIOEN page.

What happened

Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN) closed at TRY 12.22 on 6 November 2026, up 9.0% from TRY 11.21 the session before.

It was the fourth higher close in a row. Over 5 sessions the price is up 17.5%, and over 20 sessions it is up 28.0%.

The close is 43.8% below the highest close of the past year (TRY 21.76 on 4 Dec 2025) and 28.0% above the lowest (TRY 9.55 on 8 Oct 2026).

Volume was close to its recent average.

Across the 8 ISTANBUL stocks we track, 4 closed higher and 3 closed lower that day, with a median change of +0.27%. BIOEN's change was +9.0%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeTRY 11.21
CloseTRY 12.22
Change on the day+9.01%
Change over 5 sessions+17.50%
Change over 20 sessions+27.96%
Volume7.76 Million
Average volume, up to 20 sessions before6.36 Million
Volume against that average1.2 times
Highest close in the past yearTRY 21.76 (4 Dec 2025)
Lowest close in the past yearTRY 9.55 (8 Oct 2026)

The full chart and history are on Biotrend Cevre ve Enerji Yatirimlari A.S. (BIOEN). More from this market: ISTANBUL news today.

Want a plan for BIOEN? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.